Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with ¹⁷⁷Lu-PSMA and Combined ²²⁵Ac- and ¹⁷⁷Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A Single-Center Systematic Investigation.

The SUVmax showed a nonsignificant trend towards lower values after treatment ( Supplementary Table S4 ), while the MV of all four SG decreased significantly ( p < 0.05; right PG: median −12.2% (95%CI: −21.6 to −6.1); left PG: median –7.8% (95%CI: −20.5 to −0.1); right SMG: median −8.7% (95%CI: −16.3 to 0.4); left SMG: median –6.5% (95%CI: −12.1 to 1.1)). 3.4.

also in 5,406 other papers